Having grown up in Hawaii during the second world war, Dr. Herbert T. Nagasawa was no stranger to service and sacrifice in times of war. Yet, through the 1960s and 70s, he was saddened to see the state in which many Vietnam veterans returned home – in despair and dependant on drugs and alcohol.
Dr. Nagasawa’s own despair would reach its lowest point when his brother returned as one of those veterans, dependent upon alcohol to numb the physical and mental pain, while his liver and body were ravaged by the effects of alcohol poisoning and cirrhosis.
At the time, the drug Antabuse was the best means of combating drinking by causing a severe reaction to alcohol to prevent its further use, but it couldn’t mitigate the damage done. Determined to do better, Dr. Nagasawa sought to develop a way to better prevent alcoholic’s from developing fatty livers, thereby reducing the risk of cirrhosis and liver failure.
After years of research, Nagasawa and his team noticed that higher levels of glutathione exhibited protective benefits for the liver from toxins. From that observation, Dr. Nagasawa and his team worked to find a way to boost the body’s natural production of glutathione – years of trial and error which would result in the proven and patented molecule known as RiboCeine™.
RiboCeine, once ingested, enters the bloodstream and delivers cysteine and ribose direct to the body’s cells, not only supporting glutathione production but also providing important fuel and energy for those cells. Today, RiboCeine is the keystone ingredient in several of Max International’s products, including Cellgevity, MaxOne, and MaxATP.
This important breakthrough was realized because one man sought to do more for the people that he saw suffering.